ArticleCancer drug resistance (Alhambra, Calif.)2025

Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy.

Yu-Qing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.